Alpha-cyano-4-hydroxycinnamic acid alleviates renal fibrosis and inflammation in chronic kidney disease

References

• Ai K, Zhu X, Kang Y, Li H, Zhang L. 2020. Mir-130a-3p inhibition protects against renal fibrosis in vitro via the tgf-beta1/smad pathway by targeting snon. Exper Mol Pathol. 112:104358. doi:10.1016/j.yexmp.2019.104358.
   PubMed Web of Science ®Google Scholar
• Allen AE, Martin EA, Greenwood K, Grant C, Vince P, Lucas RJ, Redfern WS. 2020. Effects of a monocarboxylate transport 1 inhibitor, azd3965, on retinal and visual function in the rat. Brit J Pharmacol. 177(20):4734–4749. doi:10.1111/bph.15239.
   PubMed Web of Science ®Google Scholar
• Bai M, Lei J, Wang S, Ding D, Yu X, Guo Y, Chen S, Du Y, Li D, Zhang Y, et al. 2019. Bmp1 inhibitor UK 383,367 attenuates renal fibrosis and inflammation in CKD. Amer J Physiol Renal Physiol. 317(6):F1430–F1438. doi:10.1152/ajprenal.00230.2019.
   PubMed Web of Science ®Google Scholar
• Baradaran Ghavami S, Chaleshi V, Derakhshani S, Aimzadeh P, Asadzadeh-Aghdaie H, Zali MR. 2017. Association between tnf-alpha rs1799964 and raf1 rs1051208 microrna binding site snp and gastric cancer susceptibility in an Iranian population. Gastroenterol Hepatol Bed Bench. 10(3):214–219.
   PubMedGoogle Scholar
• Baumann F, Leukel P, Doerfelt A, Beier CP, Dettmer K, Oefner PJ, Kastenberger M, Kreutz M, Nickl-Jockschat T, Bogdahn U, et al. 2009. Lactate promotes glioma migration by tgf-beta2-dependent regulation of matrix metalloproteinase-2. Neurooncology. 11(4):368–380. doi:10.1215/15228517-2008-106.
   PubMed Web of Science ®Google Scholar
• Cruceriu D, Baldasici O, Balacescu O, Berindan-Neagoe I. 2020. The dual role of tumor necrosis factor-alpha (tnf-alpha) in breast cancer: Molecular insights and therapeutic approaches. Cell Oncol (Dordr). 43(1):1–18. doi:10.1007/s13402-019-00489-1.
   PubMed Web of Science ®Google Scholar
• Del Prete E, Lutz TA, Scharrer E. 2004. Inhibition of glucose oxidation by alpha-cyano-4-hydroxycinnamic acid stimulates feeding in rats. Physiol Behav. 80(4):489–498. doi:10.1016/j.physbeh.2003.10.007.
   PubMed Web of Science ®Google Scholar
• Ding H, Jiang L, Xu J, Bai F, Zhou Y, Yuan Q, Luo J, Zen K, Yang J. 2017. Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis. Amer J Physiol Renal Physiol. 313(3):F561–F575. doi:10.1152/ajprenal.00036.2017.
   PubMed Web of Science ®Google Scholar
• Drozdzik M, Szelag-Pieniek S, Grzegolkowska J, Lapczuk-Romanska J, Post M, Domagala P, Mietkiewski J, Oswald S, Kurzawski M. 2020. Monocarboxylate transporter 1 (mct1) in liver pathology. Intern J Mol Sci. 21(5) doi:10.3390/ijms21051606
   Web of Science ®Google Scholar
• Dufour AM, Alvarez M, Russo B, Chizzolini C. 2018. Interleukin-6 and type-i collagen production by systemic sclerosis fibroblasts are differentially regulated by interleukin-17a in the presence of transforming growth factor-beta 1. Front Immunol. 9:1865. doi:10.3389/fimmu.2018.01865.
   PubMed Web of Science ®Google Scholar
• Egli-Spichtig D, Imenez Silva PH, Glaudemans B, Gehring N, Bettoni C, Zhang MYH, Pastor-Arroyo EM, Schonenberger D, Rajski M, Hoogewijs D, et al. 2019. Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation. Kidney Intern. 96(4):890–905. doi:10.1016/j.kint.2019.04.009.
   PubMed Web of Science ®Google Scholar
• Guo C, Huang T, Wang QH, Li H, Khanal A, Kang EH, Zhang W, Niu HT, Dong Z, Cao YW. 2019. Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells. Cancer Cell Intern. 19:170. doi:10.1186/s12935-019-0889-8.
   PubMed Web of Science ®Google Scholar
• Hewitson TD, Smith ER. 2021. A metabolic reprogramming of glycolysis and glutamine metabolism is a requisite for renal fibrogenesis-why and how? Front Physiol. 12:645857. doi:10.3389/fphys.2021.645857.
   PubMed Web of Science ®Google Scholar
• Kaspar CD, Bholah R, Bunchman TE. 2016. A review of pediatric chronic kidney disease. Blood Purif. 41(1-3):211–217. doi:10.1159/000441737.
   PubMed Web of Science ®Google Scholar
• Lee M, Harley G, Katerelos M, Gleich K, Sullivan MA, Laskowski A, Coughlan M, Fraser SA, Mount PF, Power DA. 2020. Mutation of regulatory phosphorylation sites in pfkfb2 worsens renal fibrosis. Sci Rep. 10(1):14531. doi:10.1038/s41598-020-71475-z.
   PubMed Web of Science ®Google Scholar
• Le Floch R, Chiche J, Marchiq I, Naiken T, Ilc K, Murray CM, Critchlow SE, Roux D, Simon MP, Pouyssegur J. 2011. Cd147 subunit of lactate/h+ symporters mct1 and hypoxia-inducible mct4 is critical for energetics and growth of glycolytic tumors. Proc Nat Acad Sci U.S.A. 108(40):16663–16668. doi:10.1073/pnas.1106123108.
   PubMed Web of Science ®Google Scholar
• Lemos DR, McMurdo M, Karaca G, Wilflingseder J, Leaf IA, Gupta N, Miyoshi T, Susa K, Johnson BG, Soliman K, et al. 2018. Interleukin-1beta activates a myc-dependent metabolic switch in kidney stromal cells necessary for progressive tubulointerstitial fibrosis. J Amer Soc Nephrol. 29(6):1690–1705. doi:10.1681/ASN.2017121283.
   PubMed Web of Science ®Google Scholar
• Lovisa S, Fletcher-Sananikone E, Sugimoto H, Hensel J, Lahiri S, Hertig A, Taduri G, Lawson E, Dewar R, Revuelta I, et al. 2020. Endothelial-to-mesenchymal transition compromises vascular integrity to induce myc-mediated metabolic reprogramming in kidney fibrosis. Sci Signal. 13(635) doi:10.1126/scisignal.aaz2597
   PubMed Web of Science ®Google Scholar
• Manning Fox JE, Meredith D, Halestrap AP. 2000. Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J Physiol. 529(Pt 2):285–293. doi:10.1111/j.1469-7793.2000.00285.x.
   PubMed Web of Science ®Google Scholar
• Miranda-Goncalves V, Honavar M, Pinheiro C, Martinho O, Pires MM, Pinheiro C, Cordeiro M, Bebiano G, Costa P, Palmeirim I, et al. 2013. Monocarboxylate transporters (mcts) in gliomas: Expression and exploitation as therapeutic targets. Neuro Oncol. 15(2):172–188. doi:10.1093/neuonc/nos298.
   PubMed Web of Science ®Google Scholar
• Perretta-Tejedor N, Munoz-Felix JM, Duwel A, Quiros-Luis Y, Fernandez-Martin JL, Morales AI, Lopez-Hernandez FJ, Lopez-Novoa JM, Martinez-Salgado C. 2019. Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease. Acta Physiol. 226(2):e13247. doi:10.1111/apha.13247.
   PubMed Web of Science ®Google Scholar
• Rowe I, Chiaravalli M, Mannella V, Ulisse V, Quilici G, Pema M, Song XW, Xu H, Mari S, Qian F, et al. 2013. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat Med. 19(4):488–493. doi:10.1038/nm.3092.
   PubMed Web of Science ®Google Scholar
• Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, Saedeleer D, Kennedy CJ, Diepart KM, Jordan C, F B, et al. 2008. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest. 118(12):3930–3942. doi:10.1172/JCI36843.
   PubMed Web of Science ®Google Scholar
• Tan C, Gu J, Li T, Chen H, Liu K, Liu M, Zhang H, Xiao X. 2021. Inhibition of aerobic glycolysis alleviates sepsisinduced acute kidney injury by promoting lactate/sirtuin 3/ampkregulated autophagy. Intern J Mol Med. 47(3) doi:10.3892/ijmm.2021.4852
   Web of Science ®Google Scholar
• Uddin M, Kawami M, Yumoto R, Takano M. 2020. Effect of transforming growth factor-beta1 on functional expression of monocarboxylate transporter 1 in alveolar epithelial a549 cells. Naunyn-Schmiedeberg's Arch Pharmacol. 393(5):889–896. doi:10.1007/s00210-019-01802-3.
   Google Scholar
• Wang L, Zhu R, Wang J, Yu S, Wang J, Zhang Y. 2020. Nrf2 activation enhances muscular mct1 expression and hypoxic exercise capacity. Med Sci Sports Exerc. 52(8):1719–1728. doi:10.1249/MSS.0000000000002312.
   PubMed Web of Science ®Google Scholar
• Waters JP, Pober JS, Bradley JR. 2013. Tumour necrosis factor and cancer. J Pathol. 230(3):241–248. doi:10.1002/path.4188.
   PubMed Web of Science ®Google Scholar
• Yuan B, Peng Q, Cheng J, Wang M, Zhong J, Qi J, Gao GF, Shi Y. 2022. Structure of the ebola virus polymerase complex. Nature. 610(7931):394–401. doi:10.1038/s41586-022-05271-2.
   PubMed Web of Science ®Google Scholar
• Zhang G, Darshi M, Sharma K. 2018a. The warburg effect in diabetic kidney disease. Sem Nephrol. 38(2):111–120. doi:10.1016/j.semnephrol.2018.01.002.
   PubMed Web of Science ®Google Scholar
• Zhang G, Zhang Y, Dong D, Wang F, Ma X, Guan F, Sun L. 2018b. Mct1 regulates aggressive and metabolic phenotypes in bladder cancer. J Cancer. 9(14):2492–2501. doi:10.7150/jca.25257.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dai Y, Raman A, Daniel E, Metcalf J, Reif G, Pierucci-Alves F, Wallace DP. 2020. Overexpression of tgf-beta1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease. Amer J Physiol Renal Physiol. 319(6):F1135–F1148. doi:10.1152/ajprenal.00366.2020.
   PubMed Web of Science ®Google Scholar
• Zhou HL, Zhang R, Anand P, Stomberski CT, Qian Z, Hausladen A, Wang L, Rhee EP, Parikh SM, Karumanchi SA, et al. 2019. Metabolic reprogramming by the s-nitroso-coa reductase system protects against kidney injury. Nature. 565(7737):96–100. doi:10.1038/s41586-018-0749-z.
   PubMed Web of Science ®Google Scholar